The Response of Drug Expenditures to Non-Linear Contract Design: Evidence From Medicare Part D

doi 10.3386/w19393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Bureau of Economic Research

Related search

The Response of Drug Expenditure to Nonlinear Contract Design: Evidence From Medicare Part D *

Quarterly Journal of Economics
EconomicsEconometrics
2015English

Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D

2015English

Salience, Myopia, and Complex Dynamic Incentives: Evidence From Medicare Part D

2015English

Radiation Oncology Drug Prescription Patterns in Medicare Part D

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

ME1 Effect of Medicare Part D on Drug Utilization, Drug Expenditures, and Health Care Spending in Patients With Chronic Pulmonary Obstructive Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Changes to Medicare Part D: Who Benefits?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2010English

Choice Inconsistencies Among the Elderly: Evidence From Plan Choice in the Medicare Part D Program

2009English

Government Payments and Insurer Benefit Design in Medicare Part D

SSRN Electronic Journal
2014English

Insurers’ Response to Selection Risk: Evidence From Medicare Enrollment Reforms

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy